Colorectal carcinoma in pediatric patients: A comparison with adult tumors, treatment and outcomes from the National Cancer Database
- PMID: 26703433
- DOI: 10.1016/j.jpedsurg.2015.11.005
Colorectal carcinoma in pediatric patients: A comparison with adult tumors, treatment and outcomes from the National Cancer Database
Abstract
Background: Pediatric colorectal cancer (CRC) is rare. Comparison with adult CRC tumors, management, and outcomes may identify opportunities for improvement in pediatric CRC care.
Study design: CRC patients in the National Cancer Data Base from 1998 to 2011, were grouped into Pediatric (≤21years), early onset adult (22-50) and older adult (>50) patients. Groups were compared with χ(2) and survival analysis.
Results: A total of 918 pediatric (Ped), 157,779 early onset adult (EA), and 1,304,085 older adults (OA) were identified (p<0.01 for all comparisons). Patients ≤50 presented more frequently with stage 3 and 4 disease (Ped: 62.0%, EA: 49.7%, OA: 37.3%) and rectal cancer (Ped: 23.6%, EA: 27.5%, OA: 19.2%). Pediatric histology was more likely signet ring, mucinous, and poorly differentiated. Initial treatment was usually surgery, but patients ≤50 were more likely to have radiation (Ped: 15.1%, EA: 18.6%, and OA: 9.2%) and chemotherapy (Ped: 42.0%, EA: 38.2%, and OA: 22.7%). Children and older adults showed poorer overall survival at 5years when compared to early onset adults. Adjusting for covariates, age ≤21 was a significant predictor of mortality for colon and rectal cancers (colon HR: 1.22, rectal HR: 1.69).
Conclusions: This is the largest cohort of pediatric CRC patients, revealing more aggressive tumor histology and behavior in children, particularly in rectal cancer. Despite standard oncologic treatment, age ≤21 was a significant predictor of mortality. This is likely owing to worse tumor biology rather than treatment disparities and may signal the need for different therapeutic strategies.
Keywords: Colon cancer; NCDB; Outcomes; Pediatric; Rectal cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.J Gastrointest Cancer. 2021 Jun;52(2):719-727. doi: 10.1007/s12029-020-00460-6. J Gastrointest Cancer. 2021. PMID: 32743731
-
Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.Eur J Cancer. 2015 Sep;51(13):1675-82. doi: 10.1016/j.ejca.2015.06.005. Epub 2015 Jul 6. Eur J Cancer. 2015. PMID: 26159248
-
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.Ann Surg Oncol. 2012 Sep;19(9):2814-21. doi: 10.1245/s10434-012-2321-7. Epub 2012 Apr 4. Ann Surg Oncol. 2012. PMID: 22476818 Free PMC article.
-
[Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].Zentralbl Chir. 2013 Aug;138(4):427-33. doi: 10.1055/s-0031-1283870. Epub 2012 Jan 24. Zentralbl Chir. 2013. PMID: 22274919 Review. German.
-
Mucinous carcinoma--just another colon cancer?Dis Colon Rectum. 1993 Jan;36(1):49-54. doi: 10.1007/BF02050301. Dis Colon Rectum. 1993. PMID: 8380140 Review.
Cited by
-
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.EJC Paediatr Oncol. 2023 Dec;2:100024. doi: 10.1016/j.ejcped.2023.100024. Epub 2023 Jul 20. EJC Paediatr Oncol. 2023. PMID: 37829670 Free PMC article.
-
Emergency management of colon adenocarcinoma in an adolescent female: A rare case report.Clin Case Rep. 2023 Sep 18;11(9):e7930. doi: 10.1002/ccr3.7930. eCollection 2023 Sep. Clin Case Rep. 2023. PMID: 37731969 Free PMC article.
-
Children's Oncology Group's 2023 blueprint for research: Rare tumors.Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30574. doi: 10.1002/pbc.30574. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37458616
-
Colorectal Carcinoma in Childhood.JPGN Rep. 2020 Dec 17;2(1):e039. doi: 10.1097/PG9.0000000000000039. eCollection 2021 Feb. JPGN Rep. 2020. PMID: 37206941 Free PMC article. No abstract available.
-
Pathological complete response after neoadjuvant immunotherapy combined with chemotherapy in pediatric rectal carcinoma: A case report.Front Immunol. 2022 Dec 5;13:1036181. doi: 10.3389/fimmu.2022.1036181. eCollection 2022. Front Immunol. 2022. PMID: 36544760 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical